Genpact Stock Plummets to New 52-Week Low at $33.74

Genpact has reached a new 52-week low, trading at USD 33.74 on April 24, 2026. This marks a significant decline for the small-cap company, which operates within the miscellaneous industry and has a market capitalization of USD 6,540 million. Over the past year, Genpact's performance has been relatively modest, with a return of 4.38%, especially when compared to the S&P 500's impressive 30.64% gain. Despite the recent price drop, Genpact maintains a P/E ratio of 12.00, indicating a potentially attractive valuation relative to its earnings. The company boasts a strong return on equity of 22.31% and a low debt-to-equity ratio of 0.15, reflecting its financial stability. Additionally, Genpact has demonstrated healthy long-term growth, with operating profit increasing at an annual rate of 10.73%. The stock's dividend yield stands at an impressive 193.37%, and recent financial results show a peak operating cash flow of USD 649.51 million. However, it is important to note that profits have decreased by 15.8% over the past year, highlighting the need for ongoing scrutiny of the company's performance metrics.